Completed Fractional Dose Tetravalent A, C, Y, W135 Meningococcal Polysaccharide Vaccine NCT00271479 Conditions Bacterial Infections, Bacterial Infections and Mycoses, Central Nervous System Bacterial Infections, +13 more Locations Norwegian Institute of Public Health — Oslo, Norway Mbarara Epicentre Research Base — Mbarara, Uganda View Trial Details
